To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: Research

May 30, 2024
GBM: Significant Survival Data Announced

The Ivy Brain Tumor Center has announced that treatment with niraparib achieved significant improvement in survival data for newly diagnosed glioblastoma patients.

Read More
March 26, 2024
EBCI Looking to Partner with GBM Drug Development Companies to Enhance Our Fight for GBM Patient Access

The End Brain Cancer Initiative (EBCI) will attend the Glioblastoma Drug Development Summit in Boston to insert the patient voice into trial protocols and patient disease education and awareness campaigns.

Read More
March 7, 2024
Clinical Trial for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG)

SonALAsense is currently recruiting patients in a Phase 1/2 Clinical Trial in DIPG, which uses Sonodynamic Therapy (SDT).

Read More
February 22, 2024
New Website for PCNS Lymphoma

New dedicated website for the Prospect primary central nervous system lymphoma study.

Read More
February 8, 2024
Clinical Trial for Patients with Primary Central Nervous System Lymphoma (PCNSL)

Ono Pharma is actively recruiting patients with Primary Central Nervous System Lymphoma (PCNSL) for the PROSPECT Study, which is evaluating an oral medicine called Tirabrutinib.

Read More
January 29, 2024
Revolutionizing Cancer Care: Advances in Radiation Therapy for Brain Tumors

Modern radiation therapy for brain tumors, marked by precision, personalization, safety, and ongoing innovation, holds promise for enhancing patient outcomes and instilling hope in challenging diagnoses.

Read More
January 23, 2024
Clinical Study for Patients with Newly Diagnosed Metastatic Brain Tumors

The Roads Clinical Study is designed for patients diagnosed with a metastatic brain tumor.

Read More
January 9, 2024
ONLY FOUR SPOTS LEFT! Opportunity for Patients Living with rGBM

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
December 14, 2023
NEW SonALAsense Clinical Trials for rGBM & DIPG Patients

SonALAsense was founded to create hope in the face of despair with Sonodynamic Therapy (SDT), a non-invasive way to treat and eradicate deadly cancers.

Read More
November 16, 2023
 IGV-001 Phase 2b Clinical Trial

Imvax is conducting a clinical trial to assess the safety and efficacy of IGV-001, an autologous biologic-device combination product in GBM patients.

Read More
November 9, 2023
EBCI Attends SNO 2023

The End Brain Cancer Initiative team is proud to be attending the 2023 Society for Neuro-Oncology Annual Meeting (SNO)

Read More
October 20, 2023
Make YOUR Voice Heard! Raising Patient Voices with EBCI

Make your voice heard by participating in the NSCLC, LGG, or rGBM study. You will advance our understanding of the treatment and management of these diseases. 

Read More
1 2 3 5


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram